Tumor Necrosis Factor-Alpha Alters the Metabolism of Endothelial Cell Proteoglycans

References

• Wight TN. Vascular cell proteoglycans: evidence for metabolic modulation. Ciba Foundation Symposiumed Functions of proteoglycans. John Wiley and Sons Ltd., Chichester 1986; 241–259
   Google Scholar
• Camejo G. The interaction of lipids and lipoproteins with the intracellular matrix of arterial tissue: Its possible role in atherogenesis. Adv. Lipid Res. 1982; 19: 1–53
   PubMedGoogle Scholar
• Berenson GS, Radhakrishnamurthy B, Srinivasan SR, Vijayagopal P, Dalferes ERJ, Sharma C. Recent advances in molecular pathology Carbohydrate-protein macromolecules and arterial wall intergrity-A role in atherogenesis. Exp. Mol. Pathol. 1984; 41: 267–287
   PubMed Web of Science ®Google Scholar
• Kanwar YS, Hascall VC, Farquar G. Partial characterisation of newly synthesized proteoglycans isolated from glomerular basement membrane. J. Cell Biol. 1981; 90: 527–532
   PubMed Web of Science ®Google Scholar
• Marcum J A, Atha DH, Fritze LMS, Nawroth P, Stern D, Rosenberg RD. Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. J. Biol. Chem. 1986; 261: 7507–7517
   PubMed Web of Science ®Google Scholar
• Marcum JA, Rosenberg RD. Heparin like molecules with anticoagulant activity are synthesized by cultured endothelial cells. Biochem. Biophys. Res. Commun. 1985; 126: 365–372
   PubMed Web of Science ®Google Scholar
• Marcum JA, Rcilly CF, Rosenberg RD. Heparan sulfate species and blood vessel wall function. Wight TN and Mecham R Ped Biology of extracellular matrix: Biology of proteoglycans. Academic Press, Orlando, Fl 1987; 301–343
   Google Scholar
• Fritze LMS, Reilly CF, Rosenberg RD. An antiproliferative heparan sulfate species producted by postconfluent smooth muscle cells. J. Cell Biol. 1985; 100: 1041–1049
   PubMed Web of Science ®Google Scholar
• Hollmann J, Schmidt A, von Bassewitz DB., Buddecke E. The relationship of sulfated glyeosaminoglycans and cholesterol content in normal and arteriosclerotic human aorta. Arteriosclerosis 1989; 9: 154–158
   PubMedGoogle Scholar
• Nathan C, Sporn M. Cytokines in context. J. Cell Biol. 1991; 113: 981–986
   PubMed Web of Science ®Google Scholar
• Gamble JR, Harlan JM, Klebanof FSJ, Vadas MA. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. PNAS. 1985; 82: 8667–8671
   PubMed Web of Science ®Google Scholar
• Pohlman TH, Stanness KA, Beatty PG, Ochs HD, Harlan JM. An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukine 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDwl8-dependent mechanism. J. Immunology 1986; 136: 4548–4553
   PubMed Web of Science ®Google Scholar
• Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA. Recombinant tumor necrosis factorinduces procoagulant activity in cultured humanvascular endothelium: Characterization and comparison with the action of interleukin 1. Proc. Natl. Acad. Sci. 1986; 83: 4533–4537
   PubMed Web of Science ®Google Scholar
• Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J. Exp. Med. 1986; 163: 740–745
   PubMed Web of Science ®Google Scholar
• Beutler B, Mahoney J, Le Trang N., Pekala P, Cerami A. Purification of cachetin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 Cells. J. Exp. Med. 1985; 161: 984–995
   PubMed Web of Science ®Google Scholar
• Matic M, Simon SR. TNF-a release from LPS stimulated human monocytes: LPS tolerance in vitro. Cytokine 1991; 3: 576–583
   Google Scholar
• Matic M, Simon SR. Effect of intereron-g on release of tumor necrosis factor-a from lipopolysaccharide-tolerant human monocyte-derived macrophages. Infection and Immunity 1992; 60: 3756–3762
   PubMedGoogle Scholar
• Turner M, Londei M, Feldmann M. Human T cells from autoimmune and normal individuals can produce tumor necrosis factor. Eur. J. Immunol. 1987; 17: 1807–1814
   PubMed Web of Science ®Google Scholar
• Sung S, Jung LKJ, Walters JA, Chen W, Wang CY, Fu SM. Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells. Journal of Experimental Medicine 1988; 168: 1539–1551
   PubMed Web of Science ®Google Scholar
• Degliatoni G, Murphy M, Francis MK, Perussia B, Trinch-Ieri G. Natural Killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with Tumor Necrosis Factor and immune interferon. J. Exp. Med. 1985; 162: 1512–1530
   Google Scholar
• Folkman J, Haudenschild CC, Zetter BR. Long-term culture of capillary endothelial cells. PNAS. 1979; 76: 5217–5221
   PubMed Web of Science ®Google Scholar
• Russell WC, Newman C, Williamson DH. A simple cy-tochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses. Nature 1975; 253: 461–462
   PubMed Web of Science ®Google Scholar
• Saksela O, Moscatelli D. Sommer A, Rifkin DB. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 1988; 107: 743–751
   PubMed Web of Science ®Google Scholar
• Evan GI, Hancock DC. Studies on the interaction of the human c-myc protein cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins. Cell 1985; 43: 253–261
   PubMed Web of Science ®Google Scholar
• Fillit H, Damle SP, Gregory JD, Volin C, Poon-King T, Zabriskie J. Sera from patients with poststreptococcal glomerulonephritis contain antibodies to glomerular heparan sulfate proteoglycan. J. Exp. Med. 1985; 161: 277–289
   PubMed Web of Science ®Google Scholar
• Shively JE, Conrad HE. Formation of anhydrosugar in the chemical dcpolymerization of heparin. Biochemistry 1976; 15: 3932–3942
   PubMed Web of Science ®Google Scholar
• Lohse LD, Linhardt RJ. Purification and characterization of heparin lyases from Flavobacterium heparin um. J. Biol. Chem. 1992; 267: 24347–24355
   PubMed Web of Science ®Google Scholar
• Yamagata T, Saito H, Habuchi O, Suzuki S. Purification and properties of bacterial chondroitinases and chondrosul-fatases. J. Biol. Chem. 1968; 243: 1523–1535
   PubMed Web of Science ®Google Scholar
• Wright TN. Vessel proteoglycan and thrombogenesis. Grune and Stratton, Spaet THed New York 1980; 1–39
   Google Scholar
• Brenner BM, Troy JL, Ballerman BJ. Endothclium-dependent vascular responses. Mediators and mechanisms. J. Clin. Invest. 1989; 84: 1373–1378
   PubMed Web of Science ®Google Scholar
• Makie IJ, Bull HA. Normal haemostasis and its regulation. Blood Rev. 1989; 3: 237
   Google Scholar
• Rosa P, Mantovani S, Rosboch R, Huttner WB. Monesin and brefeldin A differently affect the phosphorylation and sulfation of secretory protein. J. Biol. Chem. 1882; 267: 12227–12232
   Google Scholar
• Klein NJ, Shennan GI, Heyderman RS, Levin M. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. J. Cell Sci. 1992; 102: 821–832
   PubMedGoogle Scholar
• Kobayashi M, Shimada K, Ozawa T. Human recombinant intcrleukin-lbetha-and tumor necrosis factor alpha-mediated suppression of heparin-like compounds on cultured porcine aortic endothelial cells. J. Cell Physiol. 1990; 144: 383–390
   PubMed Web of Science ®Google Scholar
• Horvath CJ, Ferro TJ, Jesmok G, Malik AB. Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. PNAS. 1988; 85: 9219–9223
   PubMed Web of Science ®Google Scholar
• Karisson K, Lindahl U, Marklund SL. Binding of human extracellular superoxide dismutase C to sulfated glycosaminoglycans. Biochem. J. 1988; 256: 29–33
   Google Scholar
• Adachi T, Kodera T, Ohta H, Hayashi K, Hirano K. The heparin binding site of human extracellular-superoxide dismutase. Ann. Biochem. Biophs. 1992; 167: 155–161
   Google Scholar
• Goldstein JL, Basu SK, Brunschede GY, Brown MS. Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans. Cell 1986; 47: 687–693
   Google Scholar
• Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes. Physiol. Rew. 1991; 2: 481–594
   Google Scholar
• Westergren-Thorsson G, Onnervik P, Fransson L. Proliferation of cultured fibroblasts is inhibited by L-iduronate-containing glycosaminoglycans. J. Cell Physiol. 1991; 147: 523–530
   PubMed Web of Science ®Google Scholar
• Buee L, Hof PR, Bouras C, Perl DP, Morrison JH, Fillit HM. Pathologic alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neurophathol. (Berl.) 1994
   Google Scholar
• Vandenabeele P. Is amyloidogenesis during Alzheimer's disease due to an IL-l/IL-6 mediated “acute phase response” in the brain?. Immunol. Today 1991; 12: 217–219
   PubMedGoogle Scholar
• Buee L, Ding W, Anderson JP., Narindrasorasak S, Kisi-Levsky R, Boyle NJ. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Brain Res. 1993; 627: 199–204
   PubMed Web of Science ®Google Scholar
• Snow AD, Willmer J, Kisilevsky R. Sulfated glycosaminoglycans a common constituent of all amyloids?. Lab. Invest. 1987; 56: 120–123
   PubMed Web of Science ®Google Scholar